Eli Lilly Corp. buy Wells Fargo & Company
Start price
09.10.23
/
50%
€535.00
Target price
09.10.24
€616.85
Performance (%)
60.55%
Price
28.08.24
€854.30
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Eli Lilly Corp. has seen massive gains of 60.55%. A total of €4.63 was paid as dividends for this prediction. This prediction currently runs until 09.10.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | 0.105% | 0.105% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Wells Fargo & Company from $615.00 to $650.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€656.50
06.02.24
06.02.24
€766.92
06.02.25
06.02.25
30.68%
28.08.24
28.08.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€584.00
24.01.24
24.01.24
€641.90
24.01.25
24.01.25
46.90%
28.08.24
28.08.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€471.80
08.08.23
08.08.23
€561.00
08.08.24
08.08.24
64.96%
09.08.24
09.08.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€307.70
13.03.23
13.03.23
€350.10
13.03.24
13.03.24
124.73%
14.03.24
14.03.24